Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer
Abstract Excessive STAT3 signalling via gp130, the shared receptor subunit for IL-6 and IL-11, contributes to disease progression and poor survival outcomes in patients with colorectal cancer. Here, we provide evidence that bazedoxifene inhibits tumour growth via direct interaction with the gp130 re...
Saved in:
| Main Authors: | Rhynelle S. Dmello, Michelle Palmieri, Pathum S. Thilakasiri, Larissa Doughty, Tracy L. Nero, Ashleigh R. Poh, Sarah Q. To, Erinna F. Lee, W. Douglas Fairlie, Lisa Mielke, Michael W. Parker, Ivan K. H. Poon, Eduard Batlle, Matthias Ernst, Ashwini L. Chand |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-04-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-024-06631-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Combination of bazedoxifene with chemotherapy and SMAC-mimetics for the treatment of colorectal cancer
by: Rhynelle S. Dmello, et al.
Published: (2025-05-01) -
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
by: Pathum Thilakasiri, et al.
Published: (2019-03-01) -
Complex IIa formation and ABC transporters determine sensitivity of OSCC to Smac mimetics
by: Yuhan Wang, et al.
Published: (2024-11-01) -
The reprogramming impact of SMAC-mimetic on glioblastoma stem cells and the immune tumor microenvironment evolution
by: Qiong Wu, et al.
Published: (2025-07-01) -
Bivalent SMAC mimetic APG-1387 reduces HIV reservoirs and limits viral rebound in humanized mice
by: Jaspreet Jain, et al.
Published: (2024-12-01)